725 related articles for article (PubMed ID: 20630773)
21. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
22. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
23. Multimodality MRI and MRA for decision making in minor stroke: a case with internal carotid and distal middle cerebral artery occlusion.
Beitzke M; Enzinger C; Beitzke D; Niederkorn K; Offenbacher H; Niederkorn-Duft M; Fazekas F
J Neuroimaging; 2011 Apr; 21(2):e156-8. PubMed ID: 20572908
[TBL] [Abstract][Full Text] [Related]
24. Successful intravenous thrombolysis in a 14-year-old boy with ischemic stroke.
Sampaio I; Abecasis F; Quintas S; Moreno T; Camilo C; Vieira M; Pinho e Melo T; Correia M
Pediatr Emerg Care; 2011 Jun; 27(6):541-3. PubMed ID: 21642792
[TBL] [Abstract][Full Text] [Related]
25. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator.
Wei XE; Zhao YW; Lu J; Li MH; Li WB; Zhou YJ; Li YH
Acta Radiol; 2015 Sep; 56(9):1119-26. PubMed ID: 25182802
[TBL] [Abstract][Full Text] [Related]
26. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
[TBL] [Abstract][Full Text] [Related]
28. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K
Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188
[TBL] [Abstract][Full Text] [Related]
29. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Sangha N; El Khoury R; Misra V; Lopez G
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
[TBL] [Abstract][Full Text] [Related]
30. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
[TBL] [Abstract][Full Text] [Related]
31. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke.
Arenillas JF; Ispierto L; Millán M; Escudero D; Pérez de la Ossa N; Dorado L; Guerrero C; Serena J; Castillo J; Dávalos A
Neurology; 2008 Jul; 71(3):190-5. PubMed ID: 18625965
[TBL] [Abstract][Full Text] [Related]
33. [Thrombolytic therapy in cerebral infarction].
Varga V; Waje-Andreassen U; Naess H; Lundstadsveen MT; Thomassen L
Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2214-7. PubMed ID: 19898567
[TBL] [Abstract][Full Text] [Related]
34. Intravenous recombinant tissue plasminogen activator thrombolysis in acute ischemic stroke due to middle cerebral artery dissection.
Doijiri R; Yokota C; Suzuki R; Toyoda K; Minematsu K
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):915.e7-9. PubMed ID: 22425201
[TBL] [Abstract][Full Text] [Related]
35. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
[TBL] [Abstract][Full Text] [Related]
36. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
[TBL] [Abstract][Full Text] [Related]
37. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
[TBL] [Abstract][Full Text] [Related]
38. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.
Messé SR; Kasner SE; Cucchiara BL; Demchuk A; Tanne D; Ouyang B; Levine SR;
J Stroke Cerebrovasc Dis; 2011; 20(3):236-40. PubMed ID: 20656508
[TBL] [Abstract][Full Text] [Related]
39. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
Kim DH; Lee DS; Nah HW; Cha JK
BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
[TBL] [Abstract][Full Text] [Related]
40. Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator.
Poncyljusz W; Falkowski A; Kojder I; Cebula E; Sagan L; Czechowski J; Walecka A
Acta Radiol; 2007 Sep; 48(7):774-80. PubMed ID: 17729010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]